Search research articles
Contact Us
Filters
Showing results (171-180 of 249) with videos related to
Page
of 25
Sort By:
Therapeutic Advances in Respiratory Disease
|
May 29, 2020
Early and sustained symptom improvement with umeclidinium/vilanterol <i>versus</i> monotherapy in COPD: a <i>post hoc</i> analysis of the EMAX randomised controlled trial
Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 8, 2021
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
Leif Bjermer, Isabelle H Boucot, François Maltais, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 10, 2021
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
December 11, 2023
Any Decrease in Lung Function is Associated With Worse Clinical Outcomes: Post Hoc Analysis of the IMPACT Interventional Trial
MeiLan K Han, Gerard J Criner, David M G Halpin, et al.
Chronic Respiratory Disease
|
October 6, 2023
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Edward M Kerwin, Paul W Jones, Leif H Bjermer, et al.
Respiratory Medicine
|
July 8, 2022
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
François Maltais, Claus F Vogelmeier, Edward M Kerwin, et al.
Digestive Diseases and Sciences
|
July 4, 1998
Giant gastric ulcers and risk factors for gastroduodenal mucosal disease in orthotopic lung transplant patients
D A Lipson, J A Berlin, H I Palevsky, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 1, 2022
International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials
Peter M A Calverley, Fernando J Martinez, Jørgen Vestbo, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 24, 2017
Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease"
David A Lipson, Helen Barnacle, Ruby Birk, et al.
Therapeutic Advances in Respiratory Disease
|
October 30, 2020
Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT
José M Marín, Luis Mateos, Juan Roldán, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 249) with videos related to
Sort By:
Page
of 25
Therapeutic Advances in Respiratory Disease
|
May 29, 2020
Early and sustained symptom improvement with umeclidinium/vilanterol <i>versus</i> monotherapy in COPD: a <i>post hoc</i> analysis of the EMAX randomised controlled trial
Edward M Kerwin, Isabelle H Boucot, Claus F Vogelmeier, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
July 8, 2021
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
Leif Bjermer, Isabelle H Boucot, François Maltais, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 10, 2021
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
December 11, 2023
Any Decrease in Lung Function is Associated With Worse Clinical Outcomes: Post Hoc Analysis of the IMPACT Interventional Trial
MeiLan K Han, Gerard J Criner, David M G Halpin, et al.
Chronic Respiratory Disease
|
October 6, 2023
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Edward M Kerwin, Paul W Jones, Leif H Bjermer, et al.
Respiratory Medicine
|
July 8, 2022
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
François Maltais, Claus F Vogelmeier, Edward M Kerwin, et al.
Digestive Diseases and Sciences
|
July 4, 1998
Giant gastric ulcers and risk factors for gastroduodenal mucosal disease in orthotopic lung transplant patients
D A Lipson, J A Berlin, H I Palevsky, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 1, 2022
International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials
Peter M A Calverley, Fernando J Martinez, Jørgen Vestbo, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 24, 2017
Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease"
David A Lipson, Helen Barnacle, Ruby Birk, et al.
Therapeutic Advances in Respiratory Disease
|
October 30, 2020
Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT
José M Marín, Luis Mateos, Juan Roldán, et al.
Page
of 25